Posted On: 02/11/2015 5:46:57 PM
Post# of 7769
Cosmo, I would like to expand on this PIMD-NJ success and you can correct me if I'm wrong with my assumptions.
Let's say MAV averages $4M in month in approved orders. Now I may be off on this, but let's say the cost of raw materials was 5-10%, that's $200-$400K we paid out each month to some other vendor for raw materials (beefing up their bottom line). Now we have PIMD approved/licensed to supply raw materials to MAV. We still pay of the cost of raw materials, but in essence since SCRC owns PIMD, SCRC is now supplying their own raw materials. If I'm not mistaken, that's a net win for SCRC of $200-$400K per month or $600-$1.2M per quarter. So along with PIMD just supplying the compounding raw materials, a $4M MAV month is really worth $4.6 - $5.2M in total revenues when we factor in PIMD revenues. Plus, this doesn't include the PIMD revenues generated servicing other pharmacies they are contracted with. What are your thoughts?
If this works out the way I think it will, it once again proves Mr. Schneiderman is a genius.
Let's say MAV averages $4M in month in approved orders. Now I may be off on this, but let's say the cost of raw materials was 5-10%, that's $200-$400K we paid out each month to some other vendor for raw materials (beefing up their bottom line). Now we have PIMD approved/licensed to supply raw materials to MAV. We still pay of the cost of raw materials, but in essence since SCRC owns PIMD, SCRC is now supplying their own raw materials. If I'm not mistaken, that's a net win for SCRC of $200-$400K per month or $600-$1.2M per quarter. So along with PIMD just supplying the compounding raw materials, a $4M MAV month is really worth $4.6 - $5.2M in total revenues when we factor in PIMD revenues. Plus, this doesn't include the PIMD revenues generated servicing other pharmacies they are contracted with. What are your thoughts?
If this works out the way I think it will, it once again proves Mr. Schneiderman is a genius.
(0)
(0)
